Atlas Trials

Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer

Clinical trial NCT01329627 · TERMINATED

Trial details

NCT number
NCT01329627
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced HER2-negative Breast Cancer
Start date
2010-08-01
Primary completion
2011-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.